Alphavirus replicon particles expressing the two major envelope proteins of equine arteritis virus induce high level protection against challenge with virulent virus in vaccinated horses.

Balasuriya UB, Heidner HW, Davis NL, Wagner HM, Hullinger PJ, Hedges JF, Williams JC, Johnston RE, David Wilson W, Liu IK, James MacLachlan N. Alphavirus replicon particles expressing the two major envelope proteins of equine arteritis virus induce high level protection against challenge with virulent virus in vaccinated horses. Vaccine. 2002 Feb 22; 20(11-12):1609-17.

View in: PubMed

subject areas

Animals
Arterivirus Infections
Cattle
Cell Line
Cricetinae
Encephalitis Virus, Venezuelan Equine
Female
Genetic Vectors
Horse Diseases
Horses
Male
Replicon
Vaccination
Vaccines, DNA
Viral Envelope Proteins
Viral Vaccines
Virulence

authors with profiles

Hans Heidner

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support